DR. BRUCE KUANG-HUAY TAN, M.D
Medical Practice at Saint Clair St, Chicago, IL

License number
Illinois 036.122820
Category
Medical Practice
Type
Otolaryngology
Address
Address
675 N Saint Clair St SUITE 15-200, Chicago, IL 60611
Phone
(312) 695-3222
(312) 695-3194 (Fax)
(202) 256-2985

Personal information

See more information about BRUCE KUANG-HUAY TAN at radaris.com
Name
Address
Phone
Bruce Tan, age 78
5605 Drexel Ave, Chicago, IL 60637
(773) 684-2066
Bruce Tan
2012 Orleans St, Chicago, IL 60614

Professional information

See more information about BRUCE KUANG-HUAY TAN at trustoria.com
Bruce Kuang-Huay Tan Photo 1
Bruce Kuang-Huay Tan, Chicago IL

Bruce Kuang-Huay Tan, Chicago IL

Specialties:
Otolaryngology
Work:
NMFF Otolaryngology
675 N Saint Clair St, Chicago, IL 60611 Northwestern Medical Faculty Foundation
675 N Sant Clair St, Chicago, IL 60611 312-695-7950
675 N Saint Clair St, Chicago, IL 60611
Education:
University of Chicago (2004)


Bruce K Tan Photo 2
Dr. Bruce K Tan, Chicago IL - MD (Doctor of Medicine)

Dr. Bruce K Tan, Chicago IL - MD (Doctor of Medicine)

Specialties:
Ear, Nose, and Throat
Address:
Northwestern Med Faclty Fdn ENT
675 N Saint Clair St SUITE 15, Chicago 60611
(312) 695-8182 (Phone)
Certifications:
Otolaryngology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English


Bruce Tan Photo 3
Bruce Tan

Bruce Tan

Location:
Greater Chicago Area
Industry:
Medical Practice


Bruce Tan Photo 4
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas

Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas

US Patent:
2011015, Jun 23, 2011
Filed:
Jan 18, 2011
Appl. No.:
13/008403
Inventors:
Louis M. Staudt - Silver Springs MD, US
George W. Wright - Rockville MD, US
Sandeep Dave - Chapel Hill SC, US
Bruce K. Tan - Chicago IL, US
Assignee:
Human Services - Bethesda MD
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information is useful in developing the appropriate therapeutic approach for use with a particular subject.